Page last updated: 2024-12-07
arsenocholine
Description
arsenocholine : An arsonium ion that is choline in which the central nitrogen has been replaced by arsenic. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
Synonyms (13)
Synonym |
(2-hydroxyethyl)trimethylarsonium |
arsonium, (2-hydroxyethyl)trimethyl- |
arsenocholine |
CHEBI:134092 |
(2-hydroxyethyl)(trimethyl)arsanium |
39895-81-3 |
unii-agj7rv2d8p |
agj7rv2d8p , |
(2-hydroxyethyl)trimethyl-arsonium |
DTXSID80873153 |
Q704767 |
arsenocholine standard solution |
(2-hydroxyethyl)trimethylarsanium |
Research Excerpts
Bioavailability
Roles (3)
Role | Description |
marine metabolite | Any metabolite produced during a metabolic reaction in marine macro- and microorganisms. |
xenobiotic | A xenobiotic (Greek, xenos "foreign"; bios "life") is a compound that is foreign to a living organism. Principal xenobiotics include: drugs, carcinogens and various compounds that have been introduced into the environment by artificial means. |
human urinary metabolite | Any metabolite (endogenous or exogenous) found in human urine samples. |
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Drug Classes (2)
Class | Description |
arsonium ion | Arsonium, AsH4(+), and derivatives formed by substitution by univalent groups. |
organoarsenic compound | |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (30)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 7 (23.33) | 18.7374 |
1990's | 4 (13.33) | 18.2507 |
2000's | 4 (13.33) | 29.6817 |
2010's | 10 (33.33) | 24.3611 |
2020's | 5 (16.67) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 27.17
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 27.17 (24.57) | Research Supply Index | 3.43 (2.92) | Research Growth Index | 4.91 (4.65) | Search Engine Demand Index | 27.81 (26.88) | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 30 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |